Paxlovid significantly reduces risk of long COVID, study finds

 In this photo illustration, Pfizer's Paxlovid is displayed on July 07, 2022 in Pembroke Pines, Florida.
In this photo illustration, Pfizer's Paxlovid is displayed on July 07, 2022 in Pembroke Pines, Florida. Photo credit Getty Images

SAN FRANCISCO (KCBS RADIO) – A new study has found that the antiviral therapy Paxlovid significantly reduces the risk of long COVID after a coronavirus infection.

For more, stream KCBS Radio now.

KCBS Radio anchors Melissa Culross and Eric Thomas spoke with Dr. Panagis Galiasatos, Director of the Tobacco Treatment Clinic and Assistant Professor of Medicine at the Johns Hopkins School of Medicine, about the study on "Ask An Expert."

DOWNLOAD the Audacy App
SIGN UP and follow KCBS Radio
Facebook | Twitter | Instagram

Featured Image Photo Credit: Getty Images